...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Two big thank you’s

I'm sure this question has been asked before, but can ZHCLF be properly held in a TFSA?

I know the shares that were spun out in 2013 can be (according to RVX correspondence at the time), and that ZHCLF are the "same" shares, but I don't know if the mechanism by which they were acquired (spin-out vs purchased on OTC) matters.

Share
New Message
Please login to post a reply